Which of the following is NOT one of the primary reasons many pharmaceutical firms use acquisitions as exemplified by Teva's frendly acquisition of Cephalon?
A) entering markets quickly.
B) overcoming the high costs of internal product development.
C) improving predictability of returns on investment.
D) extending patent rights on developed pharmaceuticals.

Question

Quizplus · Accepted Answer

Extending patent rights on developed pharmaceuticals is not a primary reason for pharmaceutical firms to use acquisitions. The other options listed - entering markets quickly, overcoming high costs of internal product development, and improving predictability of returns on investment - are common reasons for pharmaceutical acquisitions.

Which of the Following Is NOT One of the Primary